image
Hepion Pharmaceuticals, Inc. HEPA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.68
8.59 %
$ 3.94 M
Market Cap
-0.11
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-48.4 M OPERATING INCOME
-6.51%
Growth Rates
1Year -6.51%
3Years -33.98%
5Years -27.12%
7Years -12.67%
10Years -40.02%
-48.9 M NET INCOME
-15.94%
Growth Rates
1Year -15.94%
3Years -33.96%
5Years -38.94%
7Years -18.52%
10Years -24.93%
EFFICIENCY
Earnings Waterfall Hepion Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 67.1 K
Gross Profit -67.1 K
Operating Expenses 48.4 M
Operating Income -48.4 M
Other Expenses 478 K
Net Income -48.9 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 67.1 K 77.5 K 86.1 K 34.5 K 26.7 K 18.8 K 21.9 K 0 21.5 K 16.4 K 0 0
Gross Profit 67.1 K 77.5 K 86.1 K 34.5 K 26.7 K 18.8 K 21.9 K 0 21.5 K 16.4 K 0 0
OPERATING INCOME
Operating Expenses 48.4 43.6 30.4 20.1 7.8 14.6 21.0 21.0 20.8 14.0 1.7 0.8
Selling, General and Administrative Expenses 9.6 10.3 10.0 8.1 4.6 7.0 6.7 7.4 5.8 5.6 1.4 0.1
Research and Development Expenses 35.6 33.3 20.4 12.0 3.2 7.6 14.3 13.7 15.0 8.4 0.3 0.7
Operating Income (48.4) (45.5) (30.4) (20.1) (7.8) (14.6) (21.0) (21.0) (20.8) (14.0) (1.7) (0.8)
PRE-TAX INCOME
Interest Income Expense 9.46 K 10.2 K 8.86 K 31.2 K 0.6 0.3 0 0 0 0 0 0
Total Other Income (0.9) 0.4 (2.3) (0.2) (0.2) 4.6 2.1 4.2 3.8 (0.4) (3.6) 1.97 K
Pre-Tax Income (49.3) (45.1) (32.7) (20.3) (7.9) (10.0) (18.9) (16.8) (17.0) (14.3) (5.3) (0.8)
NET INCOME
Tax Provision 0.4 (2.9) 8.86 K 30.6 K (0.9) (0.5) (3.9) (1.9) (3.8) 0.4 3.6 1.97 K
Net Income (48.9) (42.2) (32.7) (20.4) (7.0) (9.4) (15.0) (14.9) (17.0) (14.3) (5.3) (0.8)
EPS 12.3 11.1 9.31 42.1 68.9 1.03 K 2.17 K 2.86 K 7.04 K 7.39 K 4.62 K 25.6